OrbiMed’s Electra Therapeutics ETRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$77.5M Buy
+6,885,170
New +$84.7M 1.41% 17

Other funds holding ETRA

OrbiMed's ETRA Position: Q3 2026 in Review

OrbiMed opened a new position in Electra Therapeutics (ETRA) in Q3 2026: 6,885,170 shares worth $77.5M. The stake represents 1.41% of the portfolio and ranks #17 among its holdings.

59 funds tracked by Wall St. Rank hold ETRA as of Q3 2026.

  • OrbiMed held 6,885,170 shares of Electra Therapeutics worth $77.5M as of Q3 2026.
  • Electra Therapeutics was a new OrbiMed position in Q3 2026.
  • Electra Therapeutics made up 1.41% of OrbiMed's portfolio in Q3 2026, its #17 holding.
  • 59 funds tracked by Wall St. Rank held Electra Therapeutics as of Q3 2026.

Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.